Skip to content

Aspergillus Infection in Patients Admitted to Hematology Ward

A Prospective Study on the Incidence of Invasive Aspergillus Infections in Hematology Patients: the Utility of Nasal Swab Screening and Environmental Sampling (AspHem)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07440485
Enrollment
193
Registered
2026-02-27
Start date
2024-02-14
Completion date
2026-03-14
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspergillus Infection

Brief summary

Aspergillus is a filamentous mould ubiquitous in the environment and the concentration of its spores in the air varies according to weather conditions and seasons. In this regard, efforts are often made to limit its diffusion in wards where fragile patients are housed (e.g., ICU, Haematology, Oncology, etc.). Indeed, in these patients, Aspergillus infections can present as pulmonary aspergillosis, invasive rhinosinusitis or angio-invasive aspergillosis with significantly high rates of morbidity and mortality, while it rarely causes disease in healthy immunocompetent subjects. Previous studies have established the correlation between nasal carriage of microorganisms and the development of an invasive infectious disease; however, those studies mainly focused on Staphylococci and Candida species. The main target of this study is to investigate the spread of Aspergillus within a hospital ward and analyse the correlation between nosocomial infection and symptom severity in a cohort of frail population.

Interventions

None listed

Sponsors

Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years old * Signature of informed consent * Admission to San Matteo's Hematology ward

Design outcomes

Primary

MeasureTime frameDescription
number of new onset of invasive aspergillosisup to 2 yearsnumber of new onset of invasive aspergillosis in patients who entered the ward with a negative swab at admission over person-time.

Secondary

MeasureTime frame
correlation between the levels of Aspergillus in the air and the number of subjects with a positive swab at dischargeup to 2 years

Countries

Italy

Contacts

CONTACTAlba Muzzi
a.muzzi@smatteo.pv.it0382/502268

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026